Junhui Sun
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 30
- Liver Disease and Transplantation 7
- Pathology and Forensic Medicine top 10%
- Biotechnology top 10%
-
- Liver Disease Diagnosis and Treatment 10
- Hepatitis B Virus Studies 7
-
- Renal cell carcinoma treatment 8
-
- Angiogenesis and VEGF in Cancer 8
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
-
- Pancreatic and Hepatic Oncology Research 5
- Co-authors
- Guan‐Hui ZhouShusen ZhengChun‐Hui NieFuliang LiZhen HuangJiping WangRong TangLiangliang Qiao
- Journals
- Frontiers in Oncology (4 papers)Oncotarget (3 papers)CardioVascular and Interventional Radiology (2 papers)
- Partner nations
- ChinaMadagascarUnited States
In The Last Decade
Junhui Sun
64 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Hepatology 567
- Pathology and Forensic Medicine 186
- Cancer Research 140
- Health Informatics 10
- Biotechnology 58
Countries citing papers authored by Junhui Sun
This map shows the geographic impact of Junhui Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhui Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhui Sun more than expected).
Fields of papers citing papers by Junhui Sun
This network shows the impact of papers produced by Junhui Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhui Sun. The network helps show where Junhui Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Junhui Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 12 | |
| 5 | 2023 | 34 | |
| 6 | 2023 | 18 | |
| 7 | 2023 | 21 | |
| 8 | 2023 | 49 | |
| 9 | Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)breakdown → | 2022 | 262 |
| 10 | 2022 | 8 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 7 | |
| 13 | 2020 | 1 | |
| 14 | 2020 | 3 | |
| 15 | 2020 | 12 | |
| 16 | 2019 | 1 | |
| 17 | 2018 | 2 | |
| 18 | 2015 | 49 | |
| 19 | 2012 | 15 | |
| 20 | 2008 | 7 |
About Junhui Sun
Junhui Sun is a scholar working on Hepatology, Biotechnology, Genetics, Pulmonary and Respiratory Medicine and Epidemiology, having authored 68 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (30 papers), Liver Disease Diagnosis and Treatment (10 papers), Renal cell carcinoma treatment (8 papers), Angiogenesis and VEGF in Cancer (8 papers), Liver Disease and Transplantation (7 papers), Hepatitis B Virus Studies (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Hepatology (567 citations), Pathology and Forensic Medicine (186 citations), Cancer Research (140 citations), Health Informatics (10 citations) and Biotechnology (58 citations). Junhui Sun has collaborated with scholars based in China, Madagascar and United States. Frequent co-authors include Guan‐Hui Zhou, Shusen Zheng, Chun‐Hui Nie, Fuliang Li, Zhen Huang, Jiping Wang, Rong Tang, Liangliang Qiao, Guoying Wang and Baogang Peng. Their work appears in journals such as Frontiers in Oncology, Oncotarget, CardioVascular and Interventional Radiology, Cell Transplantation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.